Prospective study regarding the improving effect of Ninjinyoeito on frailty and sarcopenia in older adults

Prospective study regarding the improving effect of Ninjinyoeito on frailty and sarcopenia in older adults - The effect of Ninjinyoeito on frailty and sarcopenia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033107

Enrollment

Registered

2018-06-23

Start date

2017-09-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Older adults with frailty or prefrailty

Interventions

Treatment with Ninjinyoeito for 24 weeks Observation without treatment for 24 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 65 years old or older 2. Outpatient who can walk by himself 3. MMSE score more than 24 points 4. Patient applicable of more than one item of frailty by J-CHS 5. Patient who does not correspond to exclusion criteria

Exclusion criteria

Exclusion criteria: 1. Patient who has allergic episode with Ninjinyoeito in the past 2. Patient who took Kampo medicine preparation within two weeks before examination

Design outcomes

Primary

Measure	Time frame
Changes in appetite, dietary composition, and physical activity.	—

Secondary

Measure	Time frame
Changes in the component of frailty, MMSE score, and body compositoin.	—

Countries

Japan

Contacts

Public ContactKen Shinmura

Hyogo College of Medicine Division of General Medicine, Department of Internal Medicine

ke-shimmura@hyo-med.ac.jp0798-45-6865

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026